Should I buy Amphenol (APH) stock or is it too late?

Amphenol · Information Technology · price $86

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Truist Securities — 74% of its targets hit on this sector (207 calls tested). It aims for $108 (+25 %), call made on July 31, 2026, maturing on July 31, 2027 (75 d ago).

The 8 reliable analysts $103+19 %

The 3 other firms $100+16 %

How to read it: the 8 reliable firms are not filtered by optimism — 8 aim above the price, 0 below, hence their $103 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Amphenol

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Baird	100 %	+59.1 %	14	$70 -19%
Truist Securities	100 %	+56.3 %	10	$108 +25%
JP Morgan	100 %	+55.3 %	9	$100 +16%
UBS	100 %	+49.1 %	12	$105 +22%
Citigroup	100 %	+47.8 %	15	$112 +30%
Goldman Sachs	82 %	+47.5 %	11	$116 +35%
Evercore ISI Group	100 %	+45.4 %	9	$100 +16%
B of A Securities	100 %	+37.4 %	6	$93 +8%

In short — Should you invest in Amphenol? Is it too late, still worth it? Analysts are overwhelmingly positive (91% buy, median target $100, i.e. +16%), and the most reliable on APH targets even higher. But the valuation is stretched (P/E ~43), the stock is volatile. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

91% of analysts rate it a buy (Buy consensus, 11 ratings) — a sign of market conviction.
Median price target $100, i.e. +16% from the current price ($86).
The most reliable firm on APH, Truist Securities (100% hit rate, 10 scored calls), targets $108 (call made on July 30, 2026, maturing on July 30, 2027) (+25%) in its most recent call, and $74 (call made on October 23, 2025, maturing on October 23, 2026) (-14%) in the one coming due soonest.
7 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 11 ratings, 1 is neutral.
High valuation (P/E ~43): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.

The analyst consensus on APH

Median target $100 (+16%) · 11 ratings · Buy consensus

Strong Buy00%

Buy1091%

Hold19%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Amphenol now?

We won't decide for you. The facts: 91% of analysts rate it a buy, median target $100 (+16%), and Truist Securities (most reliable on APH, 100%) targets $108. Weigh that against valuation (P/E ~43) and volatility. This is not personalized advice.

Is it too late to invest in Amphenol?

Not according to analysts: the median target ($100) is still +16% above the current price ($86) (most reliable on APH: Truist Securities, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Amphenol still worth investing in?

It depends on the gap between the price ($86) and its estimated value: analysts target $100 on median (+16%), with 91% buys (most reliable on APH: Truist Securities, 100%). Cross-check with their real reliability on APH and the cautions above. Information, not advice.

What's the main risk in buying APH?

The consensus is not unanimous: of 11 ratings, 1 is neutral.

→ Go deeper: the full Amphenol profile (consensus, analyst reliability, price target, performance).